QUIDEL CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 27 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-11-13: Reporting owner TAMERIUS JOHN; Form 3; Security Incentive Stock Option; Transaction Holding.
- 2008-11-13: Reporting owner TAMERIUS JOHN; Form 3; Security Incentive Stock Option; Transaction Holding.
- 2008-11-13: Reporting owner TAMERIUS JOHN; Form 3; Security Incentive Stock Option; Transaction Holding.
- 2008-11-13: Reporting owner TAMERIUS JOHN; Form 3; Security Incentive Stock Option; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-11-13 holding as of filing | TAMERIUS JOHN Officer (Sr. VP - Clinical/Reg Affairs) | 3 | Incentive Stock Option Derivative · Direct | Holding | $4.81 exercise price | 2008-11-13 | ||
| 2008-11-13 holding as of filing | TAMERIUS JOHN Officer (Sr. VP - Clinical/Reg Affairs) | 3 | Incentive Stock Option Derivative · Direct | Holding | $5.70 exercise price | 2008-11-13 | ||
| 2008-11-13 holding as of filing | TAMERIUS JOHN Officer (Sr. VP - Clinical/Reg Affairs) | 3 | Incentive Stock Option Derivative · Direct | Holding | $3.19 exercise price | 2008-11-13 | ||
| 2008-11-13 holding as of filing | TAMERIUS JOHN Officer (Sr. VP - Clinical/Reg Affairs) | 3 | Incentive Stock Option Derivative · Direct | Holding | $7.50 exercise price | 2008-11-13 | ||
| 2008-11-13 holding as of filing | TAMERIUS JOHN Officer (Sr. VP - Clinical/Reg Affairs) | 3 | Incentive Stock Option Derivative · Direct | Holding | $12.23 exercise price | 2008-11-13 | ||
| 2008-11-13 holding as of filing | TAMERIUS JOHN Officer (Sr. VP - Clinical/Reg Affairs) | 3 | Non-Qualified Stock Option Derivative · Direct | Holding | $16.77 exercise price | 2008-11-13 | ||
| 2008-11-10 | TAMERIUS JOHN Officer (Sr. VP - Clinical/Reg Affairs) | 4 | Incentive Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,783 22,783 owned after | $15.71 exercise price | 2008-11-13 | |
| 2008-11-10 | TAMERIUS JOHN Officer (Sr. VP - Clinical/Reg Affairs) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,512 26,512 owned after | $15.71 exercise price | 2008-11-13 | |
| 2008-10-28 | Mason Caren L Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −220,000 114,396 owned after | $3.46 exercise price | 2008-10-30 | |
| 2008-10-28 | Mason Caren L Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,561 5,106 owned after | $12.23 exercise price | 2008-10-30 | |
| 2008-06-09 | Bujarski Robert Joseph Officer (Sr. VP, General Counsel & Secy) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $17.38 exercise price | 2008-06-11 | |
| 2008-05-22 | SCHULER JACK W Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,154 12,154 owned after | $16.25 exercise price | 2008-05-27 | |
| 2008-05-22 | PULIDO MARK Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,953 15,953 owned after | $16.25 exercise price | 2008-05-27 | |
| 2008-05-22 | POLAN MARY LAKE PH D Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,154 12,154 owned after | $16.25 exercise price | 2008-05-27 | |
| 2008-05-22 | DAMMEYER RODNEY F Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,154 12,154 owned after | $16.25 exercise price | 2008-05-27 | |
| 2008-05-22 | BUECHLER KENNETH F Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,154 12,154 owned after | $16.25 exercise price | 2008-05-27 | |
| 2008-05-22 | Brown Thomas D Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,154 12,154 owned after | $16.25 exercise price | 2008-05-27 | |
| 2008-05-22 | Foley Thomas James Officer (Chief Technical Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −49,351 15,305 owned after | $5.85 exercise price | 2008-05-27 | |
| 2008-05-21 | Foley Thomas James Officer (Chief Technical Officer) | 4 | Non-qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,468 64,656 owned after | $5.85 exercise price | 2008-05-22 | |
| 2008-05-02 | Foley Thomas James Officer (Chief Technical Officer) | 4 | Incentive Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,955 12,821 owned after | $5.85 exercise price | 2008-05-06 | |
| 2008-05-02 | Foley Thomas James Officer (Chief Technical Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,500 75,124 owned after | $5.85 exercise price | 2008-05-06 | |
| 2008-05-01 | Foley Thomas James Officer (Chief Technical Officer) | 4 | Incentive Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −37,600 17,955 owned after | $5.85 exercise price | 2008-05-06 | |
| 2008-04-07 | Foley Thomas James Officer (Chief Technical Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,908 28,908 owned after | $16.77 exercise price | 2008-04-09 | |
| 2008-04-07 | McLeod Scot M Officer (Sr. VP - Operations) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,275 33,275 owned after | $16.77 exercise price | 2008-04-09 | |
| 2008-04-07 | RADAK JOHN MATTHEW Officer (Chief Financial Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +53,950 53,950 owned after | $16.77 exercise price | 2008-04-09 | |
| 2008-04-07 | Tarbox Richard C III Officer (Sr. VP - Corporate Development) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +46,407 46,407 owned after | $16.77 exercise price | 2008-04-09 | |
| 2008-04-07 | Mason Caren L Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +97,085 97,085 owned after | $16.77 exercise price | 2008-04-09 |